Cited by 979Heart Failure Treatment and ManagementHeart Rate Variability and Autonomic ControlHeart rate and cardiovascular health

The DOI matches its Crossref record; 169 of the 171 references it cites were found in a registry or an index.

The Sympathetic Nervous System in Heart Failure

Open access

Triposkiadis, Filippos, Karayannis, George, Giamouzis, Grigorios, Skoularigis, John, Louridas, George, Butler, Javed·2009·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2009.05.015

Open this paper in CoChat — free account Open PDF

Abstract

Heart failure is a syndrome characterized initially by left ventricular dysfunction that triggers countermeasures aimed to restore cardiac output. These responses are compensatory at first but eventually become part of the disease process itself leading to further worsening cardiac function. Among these responses is the activation of the sympathetic nervous system (SNS) that provides inotropic support to the failing heart increasing stroke volume, and peripheral vasoconstriction to maintain mean arterial perfusion pressure, but eventually accelerates disease progression affecting survival. Activation of SNS has been attributed to withdrawal of normal restraining influences and enhancement of excitatory inputs including changes in: 1) peripheral baroreceptor and chemoreceptor reflexes; 2) chemical mediators that control sympathetic outflow; and 3) central integratory sites. The interface between the sympathetic fibers and the cardiovascular system is formed by the adrenergic receptors (ARs). Dysregulation of cardiac beta(1)-AR signaling and transduction are key features of heart failure progression. In contrast, cardiac beta(2)-ARs and alpha(1)-ARs may function in a compensatory fashion to maintain cardiac inotropy. Adrenergic receptor polymorphisms may have an impact on the adaptive mechanisms, susceptibilities, and pharmacological responses of SNS. The beta-AR blockers and the inhibitors of the renin-angiotensin-aldosterone axis form the mainstay of current medical management of chronic heart failure. Conversely, central sympatholytics have proved harmful, whereas sympathomimetic inotropes are still used in selected patients with hemodynamic instability. This review summarizes the changes in SNS in heart failure and examines how modulation of SNS activity may affect morbidity and mortality from this syndrome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2009.05.015

Cites

169 of 169 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)
(1999) · The Lancet · doi:10.1016/s0140-6736(99)04440-2 · Cited by 5,141
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
Lechat, P. P., Brunhuber, K., Hofmann, R., Kuhn, P., Nesser, H., Slany, J., Weihs, W., Wiedermann, C. J., Wimmer, H., van Mieghem, W., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,922
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,137
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
Wittstein, I. S., Thiemann, D. R., Lima, J. A. C., Baughman, K. L., Schulman, S. P., Gerstenblith, G., Wu, K. C., Rade, J. J., Bivalacqua, T. J., & Champion, H. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043046 · Cited by 3,108
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F. M., Remme, W. J., Cody, R. J., Castaigne, A., Pérez, A. J. P., Palensky, J., & Wittes, J. T. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W. A., Cubicciotti, R. S., Sageman, W. S., Lurie, K. G., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270

Flagged first, then by citations

Show all 171 references

2 of the 171 references couldn’t be matched to a known paper.

Sorted by citations

Items 401–500 of 979

Low-Level Vagus Nerve Stimulation Reverses Cardiac Dysfunction and Subcellular Calcium Handling in Rats With Post-Myocardial Infarction Heart Failure
Zhang, Y., Chen, A., Song, L., Li, M., Luo, Z., Zhang, W., Chen, Y., & He, B. (2016) · International Heart Journal · doi:10.1536/ihj.15-516 · Cited by 16
Esmolol infusion in patients with septic shock and tachycardia: a prospective, single-arm, feasibility study
study, T. E. T. C. A. S. I. S. S.-R.-I. (.-R., Brown, S. M., Beesley, S. J., Lanspa, M. J., Grissom, C. K., Wilson, E. L., Parikh, S. M., Sarge, T., Talmor, D. S., Banner‐Goodspeed, V., et al. (2018) · Pilot and Feasibility Studies · doi:10.1186/s40814-018-0321-5 · Cited by 17
Beta-3 adrenoceptors: A potential therapeutic target for heart disease
Kayki‐Mutlu, G., Karaömerlioğlu, İ., Arioglu‐Inan, E., & ALTAN, V. M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172468 · Cited by 15
Less Loop Diuretic Use in Patients on Sacubitril/Valsartan Undergoing Remote Pulmonary Artery Pressure Monitoring
Böhm, M., Aßmus, B., Anker, S. D., Asselbergs, F. W., Brachmann, J., Brett, M., Brugts, J. J., Ertl, G., Wang, A., Hilker, L., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13665 · Cited by 15
Resolving inflammatory links between myocardial infarction and vascular dementia
Thorp, E. B., Flanagan, M. E., Popko, B., & DeBerge, M. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101600 · Cited by 17
Pulmonary Hypertension and Right Ventricle: A Pathophysiological Insight
Namazi, M., Eftekhar, S. P., Mosaed, R., Dini, S. S., & Hazrati, E. (2024) · Clinical Medicine Insights Cardiology · doi:10.1177/11795468241274744 · Cited by 15
Regulation of Cardiac Voltage-Gated Sodium Channel by Kinases: Roles of Protein Kinases A and C
Aromolaran, A. S., Chahine, M., & Boutjdir, M. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_53 · Cited by 15
Hypothalamic dysfunction in heart failure: pathogenetic mechanisms and therapeutic implications
Rigas, A., Farmakis, D. T., Papingiotis, G., Bakosis, G., & Parissis, J. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9659-7 · Cited by 15
Targeted ablation of cardiac sympathetic neurons attenuates adverse postinfarction remodelling and left ventricular dysfunction
Xiong, L., Liu, Y., Zhou, M., Wang, G., Quan, D., Shuai, W., Shen, C., Kong, B., Huang, C., & Huang, H. (2018) · Experimental Physiology · doi:10.1113/ep086928 · Cited by 15
The Interaction Analysis between the Sympathetic and Parasympathetic Systems in CHF by Using Transfer Entropy Method
Luo, D., Pan, W., Li, Y., Feng, K., & Liu, G. (2018) · Entropy · doi:10.3390/e20100795 · Cited by 15
Machine Learning Model Based on Transthoracic Bioimpedance and Heart Rate Variability for Lung Fluid Accumulation Detection: Prospective Clinical Study
Reljin, N., Posada-Quintero, H. F., Eaton-Robb, C., Binici, S., Ensom, E., Ding, E., Hayes, A., Riistama, J. M., Darling, C. E., McManus, D. D., et al. (2020) · JMIR Medical Informatics · doi:10.2196/18715 · Cited by 15
Autonomic cardiovascular reflex control of hemodynamics during exercise in heart failure with reduced ejection fraction and the effects of exercise training
Boyes, N. G., Marciniuk, D. D., Haddad, H. A., & Tomczak, C. R. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2302072 · Cited by 15
Early NT‐proBNP Decrease With Ivabradine in Ambulatory Patients With Systolic Heart Failure
Sargento, L., Satendra, M., Longo, S., Lousada, N., & dos Reis, R. P. (2013) · Clinical Cardiology · doi:10.1002/clc.22183 · Cited by 15
Acute Myocardial Infarction Inhibits the Neurogenic Tachycardic and Vasopressor Response in Rats via Presynaptic Cannabinoid Type 1 Receptor
Rudź, R., Schlicker, E., Baranowska, U., Marciniak, J., Karabowicz, P., & Malinowska, B. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.196816 · Cited by 15
Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by 123I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease
Spinelli, L., Pellegrino, T., Pisani, A., Giudice, C. A., Riccio, E., Imbriaco, M., Salvatore, M., Trimarco, B., & Cuocolo, A. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3273-5 · Cited by 15
Direct Cardiac Toxicity of the Tentacle-Only Extract From the Jellyfish Cyanea capillata Demonstrated in Isolated Rat Heart
Beilei, W., Lin, Z., He, Q., Qianqian, W., Tao, W., Jia, L., Xiaojuan, W., Ye, X., Liang, X., & Liming, Z. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318242baa1 · Cited by 15
Hyperpolarization-Activated Cyclic Nucleotide-Gated Ion (HCN) Channels Regulate PC12 Cell Differentiation Toward Sympathetic Neuron
Zhong, L.-Y., Fan, X., Shi, Z., Fan, Z., Luo, J. H., Lin, N., Liu, Y.-C., Wu, L., Zeng, X., Cao, J., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00415 · Cited by 15
Association of Plasma Renalase and Left Ventricle Mass Index in Heart Failure Patients Stratified to the Category of the Ejection Fraction: A Pilot Study
Stojanović, D. R., Mitić, V., Petrović, D., Stojanović, M., Ignjatović, A., STEFANOVIĆ, N. Z., Cvetković, T., Bojanić, V., Kocic, G. M., & Ilic, M. D. (2019) · Disease Markers · doi:10.1155/2019/7265160 · Cited by 15
GLP-1 Receptor Agonists in Heart Failure
Rahmani, A. R., Dhaliwal, S., Pastena, P., Kazakov, E., Jayaseelan, K., & Kalogeropoulos, A. P. (2025) · Biomolecules · doi:10.3390/biom15101403 · Cited by 15
Autonomic Imbalance in Cardiomyopathy and Heart Failure: From Neurobiology to Precision Neuromodulation
Talishinsky, A., Ajijola, O. A., & Khalsa, S. S. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02288-7 · Cited by 18
Aortic Thoracic Neuromodulation in Heart Failure with Preserved Ejection Fraction
Paolisso, P., Dagan, A., Gallinoro, E., Colle, C. D., Bertolone, D. T., Moyá, A., Pěnička, M., Degrieck, I., Vanderheyden, M., & Bartúnek, J. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14136 · Cited by 13
Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future
Zhou, S., Liu, Y., Huang, X., Wu, C., & Pórszász, R. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1337154 · Cited by 15
Heart Failure and Gut Microbiota: What Is Cause and Effect?
Shen, S., Tian, B., Haizhu, Z., Wang, Y., Li, T., & Cao, Y. (2025) · Research · doi:10.34133/research.0610 · Cited by 18
Prevalence of impaired coronary flow reserve and its association with left ventricular diastolic function in asymptomatic individuals with major cardiovascular risk factors
Karayannis, G., Giamouzis, G., Alexandridis, E., Kamvrogiannis, P., Butler, J., Skoularigis, J. S., & Triposkiadis, F. K. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826710389356 · Cited by 14
Self-citation
Sleep-Disordered Breathing During Congestive Heart Failure: To Intervene or Not to Intervene?
Valika, A. A., & Costanzo, M. R. (2017) · Cardiac failure review · doi:10.15420/cfr.2017:7:1 · Cited by 15
The role of mechanotransduction in heart failure pathobiology—a concise review
Krueger, W., Bender, N., Haeusler, M., & Henneberg, M. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09915-1 · Cited by 17
Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes
Casabella-Ramón, S., Jiménez-Sábado, V., Tarifa, C., Casellas, S., Lu, T. T., Izquierdo-Castro, P., Gich, I. J., Jiménez, M., Ginel, A., Palmero, M. J. G., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10071759 · Cited by 14
Genetic predisposition to left ventricular dysfunction: a multigenic and multi-analytical approach
Mishra, A., Srivastava, A., Mittal, T., Garg, N., & Mittal, B. (2014) · Gene · doi:10.1016/j.gene.2014.05.060 · Cited by 13
Acute Decompensated Heart Failure
Hammond, D. A., Smith, M. N., Lee, K. C., Honein, D., & Miller, A. D. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066616669494 · Cited by 15
Evaluation of efficacy of metoprolol in patients having heart failure with preserved ejection fraction: A randomized, double-blind, placebo-controlled pilot trial
Mittal, N., Shafiq, N., Sreenivas Reddy, S., Malhotra, S., Kumari, S., & Varma, S. (2017) · Perspectives in Clinical Research · doi:10.4103/2229-3485.210449 · Cited by 14
Nrf2 and autonomic dysregulation in chronic heart failure and hypertension
Wafi, A. M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1206527 · Cited by 16
Coronary microvascular and endothelial function regulation: Crossroads of psychoneuroendocrine immunitary signals and quantum physics [Part B]
Lin, C. D., Poretto, A., Scodro, M., Marra, M. P., Iliceto, S., & Tona, F. (2015) · Journal of Integrative Cardiology · doi:10.15761/jic.1000136 · Cited by 13
Impact of Racial Discrimination and Hostility on Adrenergic Receptor Responsiveness in African American Adults
Hill, L. K., Sherwood, A., McNeilly, M., Anderson, N. B., Blumenthal, J. A., & Hinderliter, A. L. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000547 · Cited by 13
Interactive regulation of laryngeal cancer and neuroscience
Hou, Y., Yang, X., Miao, S., Qu, G., & Meng, H. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188580 · Cited by 13
Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure
Matsushita, K., Harada, K., Miyazaki, T., Miyamoto, T., Kohsaka, S., Iida, K., Tanimoto, S., Takei, M., Hosoda, T., Yamamoto, Y., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001932 · Cited by 13
Depressive Symptoms are Associated with Heart Rate Variability Independently of Fitness: A Cross-Sectional Study of Patients with Heart Failure
Walter, F. A., Gathright, E. C., Redle, J. D., Gunstad, J., & Hughes, J. W. (2019) · Annals of Behavioral Medicine · doi:10.1093/abm/kaz006 · Cited by 13
Ventromedial Hypothalamus Activation Aggravates Hypertension Myocardial Remodeling Through the Sympathetic Nervous System
Zhou, Y., Liu, Z., Liu, Z., Zhou, H., Xu, X., Li, Z., Hu, C., Wang, Y., Zhou, Z., Wang, M., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.737135 · Cited by 13
Stellate Ganglia: A Key Therapeutic Target for Malignant Ventricular Arrhythmia in Heart Disease
Li, Y., Li, Y., Tu, H., Evans, A. J., Patel, T., Zheng, H., & Patel, K. P. (2025) · Circulation Research · doi:10.1161/circresaha.124.325384 · Cited by 12
Exercise training reduces brainstem oxidative stress and restores normal breathing function in heart failure
Díaz‐Jara, E., Díaz, H. S., Ríos-Gallardo, A. P., Ortolani, D., Andrade, D. C., Toledo, C., Pereyra, K. V., Schwarz, K. G., Ramírez, G., Ortíz, F. C., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.06.032 · Cited by 12
How Do Modulators Affect the Orthosteric and Allosteric Binding Pockets?
Chen, C.-J., Jiang, C., Yuan, J., Chen, M., Cuyler, J., Xie, X., & Feng, Z. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00749 · Cited by 12
Monoamine oxidase A and organic cation transporter 3 coordinate intracellular β1AR signaling to calibrate cardiac contractile function
Wang, Y., Zhao, M., Xu, B. Y., Bahriz, S. M. F. M., Zhu, C., Jovanović, A., Ni, H., Jacobi, A. A., Kaludercic, N., Lisa, F. D., et al. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00944-5 · Cited by 12
Endovascular Baroreflex Amplification With the MobiusHD Device in Patients With Heart Failure and Reduced Ejection Fraction: Interim Analysis of the First-in-Human Results
Piayda, K., Sievert, K., Sievert, H., Shaburishvili, T., Gogorishvili, I., Rothman, M. T., Januzzi, J. L., Lindenfeld, J. M., & Stone, G. W. (2022) · Structural Heart · doi:10.1016/j.shj.2022.100086 · Cited by 12
Modern Approaches for the Treatment of Heart Failure: Recent Advances and Future Perspectives
Popa, I. P., Haba, M. Ș. C., Maranducă, M. A., Tănase, D. M., Șerban, D. N., Șerban, L., Iliescu, R., & Tudorancea, I. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091964 · Cited by 13
Outpatient management of chronic heart failure
Kaldara, E. E., Sanoudou, D., Adamopoulos, S. N., & Nanas, J. N. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.978286 · Cited by 12
Nebivolol for the treatment of heart failure
Riva, N., & Lip, G. Y. H. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.625011 · Cited by 13
Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure
da Silva, M. I. M., Ferreira, M. J., & Moreira, A. P. (2013) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2013.06.006 · Cited by 12
Cardioprotective and Anti-arrhythmic Effects of Magnesium Pretreatment Against Ischaemia/Reperfusion Injury in Isoprenaline-Induced Hypertrophic Rat Heart
Amoni, M., Kelly-Laubscher, R. F., Petersen, M., & Gwanyanya, A. (2015) · Cardiovascular Toxicology · doi:10.1007/s12012-015-9355-6 · Cited by 12
Bucindolol improves right ventricle function in rats with pulmonary arterial hypertension through the reversal of autonomic imbalance
Seolin, B. G. D. L., Colombo, R., Bonetto, J. H. P., Teixeira, R. B., Donatti, L. M., Casali, K. R., Godoy, A. E. G., Litvin, I. E., Schenkel, P. C., Araújo, A. S. D. R., et al. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.12.028 · Cited by 12
Role of angiotensin II type I (AT1 A1166C) receptor polymorphism in susceptibility of left ventricular dysfunction
Mishra, A., Srivastava, A., Kumar, S., Mittal, T., Garg, N., Agarwal, S. K., Pande, S., & Mittal, B. (2015) · Indian Heart Journal · doi:10.1016/j.ihj.2015.04.013 · Cited by 12
Sympathetic Dysautonomia in Heart Failure by 123I-MIBG: comparison between Chagasic, non-Chagasic and heart transplant patients
Marino, V. S. P., Dumont, S. M., Mota, L. D. G., Braga, D. D. S., de Freitas, S. S., & Moreira, M. D. C. V. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180124 · Cited by 12
Efeitos do treinamento muscular inspiratório no controle autonômico: revisão sistemática
de Almeida, L. B., Seixas, M. B., Trevizan, P. F., CamarotiLaterza, M., da Silva, L. P., & Martinêz, D. G. (2018) · Fisioterapia e Pesquisa · doi:10.1590/1809-2950/17015425032018 · Cited by 12
Impact of body mass index on cardiac adrenergic derangement in heart failure patients: a 123I-mIBG imaging study
Komici, K., Bencivenga, L., Paolillo, S., Gargiulo, P., Formisano, R., Assante, R., Nappi, C., Marsico, F., D’Antonio, A., Simini, G. D., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04658-0 · Cited by 12
Neuromodulation Therapy in Heart Failure: Combined Use of Drugs and Devices
Sobowale, C., Hori, Y., & Ajijola, O. A. (2020) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2020.110705 · Cited by 13
Heart Failure Spending Function: An Investment Framework for Sequencing and Intensification of Guideline-Directed Medical Therapies
Allen, L. A., Teerlink, J. R., Gottlieb, S. S., Ahmad, T., Lam, C. S. P., & Psotka, M. A. (2022) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.008594 · Cited by 12
Conducting the G-protein coupled receptor (GPCR) signaling symphony in cardiovascular diseases: New therapeutic approaches
Belmonte, S. L., & Blaxall, B. C. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.03.001 · Cited by 12
The Correlation of ECG Parameters to the Sub-THz Reflection Coefficient of Human Skin
Safrai, E., Ishai, P. B., Polsman, A., Einav, S., & Feldman, Y. D. (2014) · IEEE Transactions on Terahertz Science and Technology · doi:10.1109/tthz.2014.2342499 · Cited by 12
Testosterone deficiency reduces the effects of late cardiac remodeling after acute myocardial infarction in rats
Corrêa, R. D. A. F., Júnior, R. F. R., Mendes, S. B. O., dos Santos, P. M., da Silva, M. V. A., Silva, D. F., Biral, I. P., de Batista, P. R., Vassallo, D. V., Bittencourt, A. S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213351 · Cited by 12
Vericiguat en insuficiencia cardíaca: de la evidencia científica a la práctica clínica
González‐Juanatey, J. R., Anguita-Sánchez, M. P., Bayés‐Genís, A., Colet, J. C., Quintana, A. G., Mayoral, A. R., Zamorano-Gómez, J. L., Cepeda-Rodrigo, J. M., & Manzano, L. (2022) · Revista Clínica Española · doi:10.1016/j.rce.2021.12.005 · Cited by 11
Relationships among norepinephrine levels, exercise capacity, and chronotropic responses in heart failure patients
Grosman‐Rimon, L., Wright, E., Sabovich, S., Rimon, J., Gleitman, S., Sudarsky, D., Lubovich, A., Gabizon, I., Lalonde, S. D., Tsuk, S., et al. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10232-y · Cited by 11
Heart failure patients demonstrate impaired changes in brachial artery blood flow and shear rate pattern during moderate‐intensity cycle exercise
Benda, N. M. M., Seeger, J. P. H., van Lier, D. P. T., Bellersen, L., van Dijk, A. P. J., Hopman, M. T. E., & Thijssen, D. H. J. (2015) · Experimental Physiology · doi:10.1113/ep085040 · Cited by 11
Heart Rate Variability Biofeedback for Postconcussion Syndrome: Implications for Treatment
Lagos, L. M., Bottiglieri, T. S., Vaschillo, B., & Vaschillo, E. G. (2012) · Biofeedback · doi:10.5298/1081-5937-40.4.05 · Cited by 11
Effects of thoracic epidural analgesia on plasma cAMP and cGMP levels in patients with heart failure
Li, Q., & Liu, F. (2013) · Journal of Cardiothoracic Surgery · doi:10.1186/1749-8090-8-217 · Cited by 11
Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis
Matsue, Y., Shiraishi, A., Kagiyama, N., Yoshida, K., Kume, T., Okura, H., Suzuki, M., Matsumura, A., Yoshida, K., & Hashimoto, Y. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0817-y · Cited by 11
Identification of risk factors for failure in patients with skin and soft tissue infections
Cieri, B., Conway, E. L., Sellick, J. A., & Mergenhagen, K. A. (2018) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2018.04.046 · Cited by 11
Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation
Mordi, I. R., Santema, B. T., Kloosterman, M., Choy, A. M., Rienstra, M., Gelder, I. C. V., Anker, S. D., Cleland, J. G. F., Dickstein, K., Filippatos, G., et al. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1409-x · Cited by 11
Unraveling the interplay between dipeptidyl peptidase 4 and the renin-angiotensin system in heart failure
Arruda-Junior, D. F., Salles, T. A., Martins, F. L., Antônio, E. L., Tucci, P. J. F., Gowdak, L. H. W., Tavares, C. A. M., & Girardi, A. C. C. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120757 · Cited by 11
Baroreflex Activation Therapy in Advanced Heart Failure Therapy: Insights from a Real-World Scenario
Guckel, D., Eitz, T., Hamriti, M. E., BRAUN, M. U., Khalaph, M., Imnadze, G., Fink, T., Sciacca, V., Sohns, C., Sommer, P., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14190 · Cited by 11
Brain Dopamine–Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects
Cincotta, A. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713255 · Cited by 11
The heart-bone connection: relationships between myocardial infarction and osteoporotic fracture
Tjandra, P. M., Ripplinger, C. M., & Christiansen, B. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00576.2023 · Cited by 12
Is there a heart rate paradox in acute heart failure?
Lourenço, P., Ribeiro, A., Cunha, F. M., Pintalhão, M., Marques, P. S., Cunha, F., Silva, S., & Bettencourt, P. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.129 · Cited by 11
Utilização da cintigrafia com iodo-123-metaiodobenzilguanidina na estratificação do risco de morte súbita na insuficiência cardíaca
da Silva, M. I. M., Ferreira, M. J., & Moreira, A. P. (2013) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2012.11.003 · Cited by 11
Heart Failure Pharmacogenetics: Past, Present, and Future
Davis, H. M., & Johnson, J. A. (2011) · Current Cardiology Reports · doi:10.1007/s11886-011-0181-6 · Cited by 11
β‐Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In‐Hospital and 12‐Month Outcome: Results From the GULF‐RACE 2 (Gulf Registry of Acute Coronary Events‐2)
Khalil, C. A., AlHabib, K. F., Singh, R., Asaad, N., AlFaleh, H., Alsheikh-Ali, A. A. A., Sulaiman, K., Alshamiri, M. Q., Alshaer, F., Almahmeed, W. A., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007631 · Cited by 11
Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels
Goulding, J., Mistry, S. J., Soave, M., Woolard, J., Briddon, S. J., White, C. W., Kellam, B., & Hill, S. J. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.779 · Cited by 13
Rethinking Heart Failure
Fürstenwerth (2012) · Cardiology Research · doi:10.4021/cr228w · Cited by 11
Risk Stratification in Heart Failure Using 123I-MIBG
Currie, G. M., Iqbal, B., Wheat, J. M., Wang, L., Trifunovic, M., Jelinek, H. F., & Kiat, H. (2011) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.111.088369 · Cited by 11
Silymarin Constituent 2,3-Dehydrosilybin Triggers Reserpine-Sensitive Positive Inotropic Effect in Perfused Rat Heart
Gabrielová, E., Zholobenko, A. V., Bartošíková, L., Nečas, J., & Modrianský, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139208 · Cited by 11
The neuropeptide galanin promotes an anti-thrombotic phenotype on endocardial endothelial cells from heart failure patients
Tyrrell, C., Toyooka, A., Khan, F. J., Thornburg, K. L. R., Mudd, J. O., & Hasan, W. (2017) · Autonomic Neuroscience · doi:10.1016/j.autneu.2017.07.002 · Cited by 11
Comorbidities of community-dwelling older adults with urinary incontinence: A scoping review
Scharp, D., Harkins, S., & Topaz, M. (2023) · Geriatric Nursing · doi:10.1016/j.gerinurse.2023.08.005 · Cited by 10
Recent advances on the Role of Gut Microbiota in the Development of Heart Failure by Mediating Immune Metabolism
Huang, Y., Ferrari, M. W., Lin, S., & Wang, Z. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102128 · Cited by 10
Transcriptional changes during isoproterenol-induced cardiac fibrosis in mice
Nanda, D., Pant, P., Machha, P., Sowpati, D. T., & Kumarswamy, R. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1263913 · Cited by 10
Notoginsenoside R1 attenuates ischemic heart failure by modulating MDM2/β arrestin2-mediated β2-adrenergic receptor ubiquitination
Chen, Q., Huang, Z., Chen, J., Tian, X., Zhang, R., Liang, Q., Liu, Z., & Cheng, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117004 · Cited by 10
Impact of right ventricular and pulmonary vascular characteristics on Impella hemodynamic support in biventricular heart failure: A simulation study.
Matsushita, H., Saku, K., Nishikawa, T., Unoki, T., Yokota, S., Sato, K., Morita, H., Yoshida, Y., Fukumitsu, M., Uemura, K., et al. (2024) · Journal of Cardiology · doi:10.1016/j.jjcc.2024.07.008 · Cited by 12
Bioelectronic block of stellate ganglia mitigates pacing‐induced heterogeneous release of catecholamine and neuropeptide Y in the infarcted pig heart
Vrabec, T. L., Bender, S. A., Chan, S., Cha, S., Haridas, S., Hanna, P., Ajijola, O. A., Shivkumar, K., Smith, C. B., & Ardell, J. L. (2024) · The Journal of Physiology · doi:10.1113/jp286924 · Cited by 11
Sympathoexcitatory input from hypothalamic paraventricular nucleus neurons projecting to rostral ventrolateral medulla is enhanced after myocardial infarction
Koba, S., Hanai, E., Kumada, N., & Watanabe, T. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00273.2020 · Cited by 10
Emerging Novel Therapies for Heart Failure
Szema, A. M., Dang, S., & Li, J. C. (2015) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s29735 · Cited by 11
Effects of autonomic balance and fluid and electrolyte changes on cardiac function in infarcted rats: A serial study of sexual dimorphism
Souza, N., Dos‐Santos, R. C., da Silveira, A. L. B., Sonoda‐Côrtes, R., Gantus, M. A. V., Fortes, M. F., & Olivares, E. L. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12543 · Cited by 10
Autonomic Predictors of Hospitalization Due to Heart Failure Decompensation in Patients with Left Ventricular Systolic Dysfunction
Daniłowicz‐Szymanowicz, L., Suchecka, J., Niemirycz-Makurat, A., Rozwadowska, K., & Raczak, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152372 · Cited by 10
α2A-adrenoceptors, but not nitric oxide, mediate the peripheral cardiac sympatho-inhibition of moxonidine
Cobos-Puc, L. E., Aguayo‐Morales, H., Silva‐Belmares, S. Y., González-Zavala, M. A., & Centurión, D. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.043 · Cited by 10
Inotropic Effects of Prostacyclins on the Right Ventricle Are Abolished in Isolated Rat Hearts With Right-Ventricular Hypertrophy and Failure
Holmboe, S., Andersen, A., Johnsen, J., Nielsen, J. M., Nørregaard, R., Bøtker, H. E., Clapp, L. H., & Nielsen‐Kudsk, J. E. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000435 · Cited by 10
Heart Failure Guidelines on Pharmacotherapy
Papadimitriou, L., HAMO, C. E., & Butler, J. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_24 · Cited by 11
Self-citation
Macrophages take centre stage in the heart–brain–kidney axis
Silljé, H. H. W., & de Boer, R. A. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.73 · Cited by 10
Early therapeutic effects of adaptive servo-ventilation on cardiac sympathetic nervous function in patients with heart failure evaluated using a combination of 11C-HED PET and 123I-MIBG SPECT
Tokuda, Y., Sakakibara, M., Yoshinaga, K., YAMADA, S., Kamiya, K., Asakawa, N., Yoshitani, T., Noguchi, K., Manabe, O., Tamaki, N., et al. (2017) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-1132-4 · Cited by 10
Efficacy of combination triple therapy with vasopressin, steroid, and epinephrine in cardiac arrest: a systematic review and meta-analysis of randomized-controlled trials
Saghafi, F., Bagheri, N., Salehi‐Abargouei, A., & Sahebnasagh, A. (2022) · Journal of Intensive Care · doi:10.1186/s40560-022-00597-5 · Cited by 10
Down-regulation of V1a vasopressin receptors in the cerebellum after myocardial infarction
Milik, E., Szczepanska‐Sadowska, E. K., Cudnoch‐Jędrzejewska, A., & Dobruch, J. T. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.049 · Cited by 10
Autonomic regulation device therapy in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials
Bendary, A., Bendary, M. M., & Salem, M. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9745-5 · Cited by 10
Cardiorenal Syndrome Type 1
Ronco, C., Lullo, L. D., & McCullough, P. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00111-4 · Cited by 10
Amygdalar activity measured using FDG-PET/CT at head and neck cancer staging independently predicts survival
Hassan, M. Z. O., Tawakol, A. A., Wang, Y., Alvi, R. M., Awadalla, M., Jones‐O’Connor, M., Bakar, R. B., Banerji, D., Rokicki, A., Zhang, L., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279235 · Cited by 10
The plasma proteome is linked with left ventricular and left atrial function parameters in patients with chronic heart failure
Kamar, S. A., Andrzejczyk, K., Petersen, T. B., Chin, J. F., Aga, Y. S., de Bakker, M., Akkerhuis, K. M., Geleijnse, M. L., Brugts, J. J., Sorop, O., et al. (2024) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeae098 · Cited by 9
Effects of Meditation and Breathing Therapy on Anxiety Improvement before and after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease: A Prospective Cohort Study
Yang, Y., Xia, L., Li, Y., Duan, T., Lv, X., & Wang, Y. (2024) · Heart and Mind · doi:10.4103/hm.hm-d-24-00027 · Cited by 10

Authors: Triposkiadis, F., Karayannis, G., Giamouzis, G., Skoularigis, J., Louridas, G., & Butler, J.
Affiliations: University Hospital of Larissa (GR)
Emory University (US)
AHEPA University Hospital (GR)
Corresponding author: Butler, Javed
ORCID: Triposkiadis, Filippos
Giamouzis, Grigorios
Skoularigis, John
Butler, Javed
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2009-11
Volume: 54
Issue: 19
Pages: 1747-1762
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2009.05.015
OpenAlex: W2097757382
Cited by: 978
References: 171
Citations by year: 2026: 40 · 2025: 44 · 2024: 69 · 2023: 46 · 2022: 74 · 2021: 54 · 2020: 59 · 2019: 77 · 2018: 59 · 2017: 62 · 2016: 71 · 2015: 66 · 2014: 63 · 2013: 58 · 2012: 61
FWCI: 6.77
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1390 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Keywords: heart failure, sympathetic nervous system, sympathetic activation, left ventricular dysfunction, beta1-adrenergic receptor, beta2-adrenergic receptor, alpha1-adrenoceptors, baroreflex, chemoreceptor reflex, beta-blockers, renin-angiotensin-aldosterone system inhibitors, cardiac inotropy, disease progression
MeSH terms: Adrenergic alpha-Antagonists, Adrenergic beta-Antagonists, Cardiotonic Agents, Digoxin, Heart Failure, Hemodynamics, Humans, Parasympathetic Nervous System, Polymorphism, Genetic, Receptors, Adrenergic, Renin-Angiotensin System, Sympathetic Nervous System, Sympatholytics, Sympathomimetics, Randomized Controlled Trials as Topic, Exercise Tolerance, Receptors, Adrenergic, alpha-1, Receptors, Adrenergic, beta-2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Sympathetic Nervous System in Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks